Challenging cases of renal cell cancers with or without tumor thrombus during the covid-19 pandemic

Research output: Contribution to journalArticlepeer-review

Abstract

Background/Aim: Large or bilateral multiple renal cell carcinoma (RCC) without/with tumor thrombus (TT) in the renal vein (RV) or inferior vena cava (IVC) poses a challenge to the surgeon due to the potential for massive hemorrhage, tumor thromboemboli and dialysis, and the situation is more critical due to Covid-19 pandemic. We report our experience and measures in dealing with challenging cases of large or multiple RCCs without/with TT during the ongoing Covid-19 pandemic. Patients and Methods: Between 4/2020-10/2020, five patients underwent RCC resection with/without TT. Patients 1 and 2 had RCCs/TT in RV; Patient 3 had RCC/TT supradiaphragmatic below right atrium; Patient-4 had a 26 cm RCC; Patient-5 had multiple RCCS as part of Birt-Hogg-Dube syndrome. Results: Patients were preoperatively tested negative for Covid-19. Operation times were 105, 85, 255, 200 and 247 minutes for Patients 1-5. Estimated blood loss was: 100, 50, 3,900,100 and 50 ml, respectively. Patient 3 underwent RCC resection en bloc with IVC/TT. Patients 1 and 2 underwent resections of RCC/TT in RV. Patient 4 underwent a 26 cm RCC resection. Patient 5 underwent laparoscopic bilateral radical nephrectomies. No immediate postoperative complications were reported. Conclusion: We successfully managed 5 challenging cases of RCCs despite the recommendations imposed by hospitals due to Covid-19 pandemic, with favorable outcomes.

Original languageEnglish (US)
Pages (from-to)335-340
Number of pages6
JournalAnticancer research
Volume41
Issue number1
DOIs
StatePublished - Jan 2021
Externally publishedYes

Keywords

  • Birt- Hogg-Dube syndrome
  • Covid-19
  • Renal cell carcinoma
  • Tumor thrombus

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Challenging cases of renal cell cancers with or without tumor thrombus during the covid-19 pandemic'. Together they form a unique fingerprint.

Cite this